Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
LENZ Therapeutics, Inc. (LENZ) had Non-Operating Income/Expense of $2.26M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$5.49M |
|
$-31.92M |
|
$0.28M |
|
$5.21M |
|
$39.66M |
|
$-34.17M |
|
|
Non-Operating Income/Expense |
$2.26M |
$-31.91M |
|
$-31.91M |
|
$-31.92M |
|
$-31.92M |
|
$-31.92M |
|
$-31.92M |
|
$-34.17M |
|
$-34.06M |
|
31.37M |
|
31.37M |
|
$-1.02 |
|
$-1.02 |
|
| Balance Sheet Financials | |
$233.28M |
|
$1.00M |
|
$3.31M |
|
$236.60M |
|
$17.21M |
|
-- |
|
$0.12M |
|
$17.33M |
|
$219.26M |
|
$219.26M |
|
$219.26M |
|
31.42M |
|
| Cash Flow Statement Financials | |
$-72.30M |
|
$70.92M |
|
$0.41M |
|
$25.18M |
|
$24.21M |
|
$-0.97M |
|
$8.79M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.90% |
|
-622.89% |
|
-622.89% |
|
-- |
|
-581.75% |
|
-581.81% |
|
$-72.33M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.07 |
|
12.41 |
|
7.25 |
|
-14.56% |
|
-14.56% |
|
-13.49% |
|
-14.56% |
|
$6.98 |
|
$-2.31 |
|
$-2.30 |
|